Overview
In this report we highlight opportunities for wearable DHTs to provide a patient-centric measure for use in clinical research. This information is driven by the patient-reported experiences in the Voice of the Patient Report associated with the FDA’s Patient-Focused Drug Development initiative.
We hope this information facilitates the consideration of digital measures as clinical development teams plan and execute their clinical trials.
This Psoriasis Digital Measure Report includes:
- Summary of the most significant symptoms reported by patients with Psoriasis and how these symptoms manifest in patients’ everyday lives
- Identified meaningful aspects of health based on the symptoms described
- Descriptions of candidate digital measures that can collect relevant data to provide clinical insights that are meaningful to patients with Psoriasis
- A link to the full Psoriasis Voice of the Patient Report
Related Resources: